Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
177Lu-DOTA-EB-FAPI
i
Other names:
177Lu-DOTA-EB-FAPI
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Xiamen University
Drug class:
FAP inhibitor
Related drugs:
‹
AAA614 (2)
177Lu-LNC1004 (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
AAA614 (2)
177Lu-LNC1004 (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
›
Associations
News
Trials
Filter by
Latest
28d
Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients with Various Solid Tumors (clinicaltrials.gov)
P2, N=28, Completed, The First Affiliated Hospital of Xiamen University | Recruiting --> Completed | Phase classification: P1 --> P2 | N=20 --> 28 | Trial completion date: Jun 2025 --> Oct 2024 | Trial primary completion date: Dec 2024 --> Sep 2024
28 days ago
Trial completion • Phase classification • Enrollment change • Trial completion date • Trial primary completion date
|
177Lu-DOTA-EB-FAPI
over1year
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer (clinicaltrials.gov)
P1, N=20, Recruiting, The First Affiliated Hospital of Xiamen University | Phase classification: P2 --> P1
over 1 year ago
Phase classification • Metastases
|
FAP (Fibroblast activation protein, alpha)
|
177Lu-DOTA-EB-FAPI
over2years
Treatment Using 177Lu-DOTA-EB-FAPI in Patients With Radioactive Iodine Refractory Thyroid Cancer (clinicaltrials.gov)
P2, N=20, Recruiting, The First Affiliated Hospital of Xiamen University | Not yet recruiting --> Recruiting
over 2 years ago
Enrollment open
|
FAP (Fibroblast activation protein, alpha)
|
177Lu-DOTA-EB-FAPI
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login